PMID: 9178335May 1, 1997Paper

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial

Psychosomatic Medicine
P J LustmanJ B McGill

Abstract

Depression is a prevalent and chronic condition in diabetes and is associated with poor glucose regulation and poor compliance with diabetes treatment. This investigation evaluated the effects of nortriptyline on depression and glycemic control to see whether depression in diabetes is treatable and whether restoring mental health contributes to improved medical outcome. Sixty-eight diabetic patients with poor glycemic control, 28 of whom had active major depression (DSM-IIIR), completed a randomized, placebo-controlled, double-blind trial involving 8 weeks of treatment with nortriptyline targeted to therapeutic plasma levels (50-150 ng/ml). Depression improvement was determined with the Beck Depression Inventory; glucose control was measured by glycated hemoglobin levels. Compliance behavior was assessed using medication dispensing devices and glucometers equipped with electronic memory. The reduction in depression symptoms was significantly greater in depressed patients treated with nortriptyline compared with those receiving placebo (-10.2 vs -5.8, p = .03). Nortriptyline was not statistically superior to placebo in reducing glycated hemoglobin of the depressed subjects (p = .5). However, path analysis indicated that the dire...Continue Reading

References

Sep 1, 1978·The Journal of Clinical Endocrinology and Metabolism·J V SantiagoF Fisher
Jan 1, 1992·Psychiatry Research·R G KatholB M Sherman
Sep 1, 1992·Psychosomatic Medicine·P J LustmanR E Clouse
Nov 1, 1992·Diabetes Care·P J LustmanR E Clouse
Apr 1, 1988·Diabetic Medicine : a Journal of the British Diabetic Association·N RobinsonS P Edmeades
May 29, 1986·The New England Journal of Medicine·G R SmithD C Ray
Sep 1, 1988·Diabetes Care·P J LustmanR E Clouse
Sep 1, 1987·Journal of General Internal Medicine·S A EisenC A Windham
Jan 1, 1986·Social Science & Medicine·R Friis, G Nanjundappa
Dec 1, 1986·The Journal of Nervous and Mental Disease·P J LustmanP E Cryer
Dec 1, 1986·The Journal of Nervous and Mental Disease·P J LustmanR E Clouse
Sep 1, 1985·Psychosomatic Medicine·N Frasure-Smith, R Prince
Jan 1, 1974·Modern Problems of Pharmacopsychiatry·A T Beck, A Beamesderfer
Oct 11, 1980·Lancet·O FakhriR M el Rawi
May 1, 1984·Psychosomatics·P S Normand, M A Jenike
Jul 1, 1984·Diabetes Care·R S MazzeH Shamoon
Oct 1, 1984·Acta Psychiatrica Scandinavica·D H Finestone, R D Weiner
Feb 1, 1994·Journal of the American Geriatrics Society·N MorisakiY Saito
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Oct 1, 1960·JAMA : the Journal of the American Medical Association·S M KAPLANW D ROSS
Jan 1, 1991·Work : a Journal of Prevention, Assessment, and Rehabilitation·P J LustmanD M Cole

❮ Previous
Next ❯

Citations

May 17, 2001·Current Psychiatry Reports·M K Popkin, E A Colon
May 26, 2001·Diabetes Care·R J AndersonP J Lustman
Apr 16, 2003·Journal of the American Geriatrics Society·Arlene F BrownUNKNOWN California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes
May 27, 2003·Diabetes Care·Johannes KruseUNKNOWN German National Health Interview and Examination Survey
Mar 24, 2005·Psychosomatic Medicine·Patrick J LustmanKenneth E Freedland
Jun 21, 2005·Journal of General Internal Medicine·Raz GrossMyrna M Weissman
Dec 13, 2006·Zeitschrift für Psychosomatische Medizin und Psychotherapie·Johannes KruseBernd Kulzer
Oct 6, 2007·International Clinical Psychopharmacology·Mirjam J KnolEibert R Heerdink
May 2, 2008·Pharmacoepidemiology and Drug Safety·M J KnolA C G Egberts
Feb 25, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·M M CollinsI J Perry
Apr 16, 2009·Journal of the American Academy of Nurse Practitioners·Hyeon-Joo LeeErika Friedmann
Sep 11, 2009·Autonomic & Autacoid Pharmacology·P J Fitzgerald
Jun 1, 2003·Expert Review of Pharmacoeconomics & Outcomes Research·Leonard E Egede, Kit Simpson
Jun 26, 2010·Diabetes/metabolism Research and Reviews·Ching-Ju ChiuElizabeth A Beverly
Feb 5, 2011·Diabetes/metabolism Research and Reviews·Yael D ReijmerUNKNOWN Utrecht Diabetic Encephalopathy Study Group
Oct 17, 2012·Der Nervenarzt·M Deuschle, U Schweiger
Jul 11, 2012·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Sue M PenckoferPatrick Lustman
Nov 29, 2012·Current Opinion in Psychiatry·Michael Deuschle
Mar 1, 2014·Western Journal of Nursing Research·Sue PenckoferPatrick J Lustman
Mar 29, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·H BaumeisterJ Bengel
Jul 9, 2016·Experimental Biology and Medicine·Allison Bickett, Hazel Tapp
Oct 18, 2016·Annals of the New York Academy of Sciences·Joshua J Joseph, Sherita H Golden
May 24, 2017·Frontiers in Molecular Neuroscience·Xiaoqin HuangYongqiang Yu
Jun 1, 2019·Expert Opinion on Pharmacotherapy·Hong-Qi LiJin-Tai Yu
Nov 25, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Shigeo MiyataJunzo Kamei
Jun 14, 2000·Psychosomatic Medicine·P J GoodnickC L DeVane
Mar 24, 2004·Current Diabetes Reports·Richard R RubinPatrick J Lustman
Aug 19, 2000·Psychosomatic Medicine·P J GoodnickC L DeVane
Aug 4, 2001·Psychosomatic Medicine·M A Van TilburgR S Surwit
Jun 24, 2004·The Diabetes Educator·John D McKellarJohn D Piette
Aug 25, 2004·Clinical Obstetrics and Gynecology·Ann J Brown
Nov 5, 2008·Current Psychiatry Reports·Patrick J LustmanRay E Clouse
Jul 29, 2006·The Diabetes Educator·Andrea CherringtonGiselle Corbie-Smith
Nov 4, 2009·Nature Reviews. Endocrinology·François Pouwer
Jan 16, 2008·European Journal of Clinical Pharmacology·Hieronymus J DerijksAntoine C G Egberts
Apr 20, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·K D BarnardR Peveler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.